Camurus AB (publ) (CAMRF)
OTCMKTS · Delayed Price · Currency is USD
68.85
-2.15 (-3.03%)
At close: Aug 22, 2025
Camurus AB Employees
As of December 31, 2024, Camurus AB had 256 total employees, including 238 full-time and 18 part-time employees. The number of employees increased by 43 or 20.19% compared to the previous year.
Employees
256
Change (1Y)
43
Growth (1Y)
20.19%
Revenue / Employee
$892,702
Profits / Employee
$282,936
Market Cap
4.62B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 256 | 43 | 20.19% |
| Dec 31, 2023 | 213 | 37 | 21.02% |
| Dec 31, 2022 | 176 | 28 | 18.92% |
| Dec 31, 2021 | 148 | 14 | 10.45% |
| Dec 31, 2020 | 134 | 14 | 11.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Elite Pharmaceuticals | 68 |
| Tian'an Technology Group | 8 |
| Glass House Brands | 374 |
| CytoDyn | 13 |
| Northwest Biotherapeutics | 25 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
| Longduoduo Company | 49 |
Camurus AB News
- 2 months ago - Camurus' POSITANO study shows treatment effects with CAM2029 in polycystic liver disease patients - PRNewsWire
- 3 months ago - Camurus and Lilly enter collaboration and license agreement for long-acting FluidCrystal® incretins - PRNewsWire
- 4 months ago - CHMP recommends approval of Oczyesa® for treatment of acromegaly in the EU - PRNewsWire
- 11 months ago - US FDA declines to approve Camurus' rare hormone disorder drug - Reuters
- 1 year ago - New publication shows effectiveness data for weekly and monthly buprenorphine injections in treating opioid dependence in individuals using fentanyl - PRNewsWire